These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2198563)

  • 1. Evaluation of drugs in Alzheimer's disease and age-associated memory impairment.
    Crook TH; Johnson BA; Larrabee GJ
    Psychopharmacol Ser; 1990; 8():37-55. PubMed ID: 2198563
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
    Crook T
    Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of perceived memory impairment: do they differ in Alzheimer's disease versus normal aging?
    Brustrom JE; Ober BA
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):402-12. PubMed ID: 9845166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [News on the Alzheimer's disease].
    Féger J
    Ann Pharm Fr; 2009 Mar; 67(2):67-8. PubMed ID: 19298888
    [No Abstract]   [Full Text] [Related]  

  • 5. Forgetfulness: age-related or Alzheimer's disease?
    Zegeer LJ
    J Neurosci Nurs; 1987 Apr; 19(2):61-2. PubMed ID: 2952741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sleep and episodic memory: a review of the literature in young healthy subjects and potential links between sleep changes and memory impairment observed during aging and Alzheimer's disease].
    Rauchs G; Harand C; Bertran F; Desgranges B; Eustache F
    Rev Neurol (Paris); 2010 Nov; 166(11):873-81. PubMed ID: 20447667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia].
    Bukatina EE; Grigor'eva IV; Smirnov OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):38-42. PubMed ID: 8009931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models].
    Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K
    Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of nalmefene and estrogen to improve memory in Alzheimer's disease.
    Weiss BL
    Am J Psychiatry; 1987 Mar; 144(3):386-7. PubMed ID: 3548443
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
    Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M
    Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.
    Soncrant TT; Raffaele KC; Asthana S; Berardi A; Morris PP; Haxby JV
    Psychopharmacology (Berl); 1993; 112(4):421-7. PubMed ID: 7871052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.
    Dröes RM; van der Roest HG; van Mierlo L; Meiland FJ
    Expert Rev Neurother; 2011 Dec; 11(12):1769-81; quiz 1782. PubMed ID: 22091600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Memory: therapeutic approach. Clinical evaluation].
    Pasquier F
    Therapie; 2000; 55(4):513-9. PubMed ID: 11098729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
    Hill NL; Mogle J
    BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.
    Ramanan VK; Saykin AJ
    Pharmacogenomics; 2015; 16(5):429-32. PubMed ID: 25916514
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kamikihito improves memory dysfunction in Alzheimer's disease].
    Tohda C; Watari H
    Nihon Yakurigaku Zasshi; 2015 May; 145(5):224-8. PubMed ID: 25958908
    [No Abstract]   [Full Text] [Related]  

  • 18. Proneness to psychological distress is associated with risk of Alzheimer's disease.
    Kelly JP; Filley CM
    Neurology; 2004 Sep; 63(5):941; author reply 941. PubMed ID: 15365165
    [No Abstract]   [Full Text] [Related]  

  • 19. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosognosia for memory deficit in amnestic mild cognitive impairment and Alzheimer's disease.
    Galeone F; Pappalardo S; Chieffi S; Iavarone A; Carlomagno S
    Int J Geriatr Psychiatry; 2011 Jul; 26(7):695-701. PubMed ID: 21495076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.